Literature DB >> 8226538

In vivo antioxidant gene expression in human airway epithelium of normal individuals exposed to 100% O2.

S C Erzurum1, C Danel, A Gillissen, C S Chu, B C Trapnell, R G Crystal.   

Abstract

Human bronchial epithelium is exquisitely sensitive to high O2 levels, with tracheobronchitis usually developing after 12 h of exposure to 100% O2. To evaluate whether this vulnerability results from inability of the bronchial epithelium to provide adequate antioxidant protection, we quantified antioxidant gene expression in bronchial epithelium of normal volunteers at baseline and after exposure to 100% O2 in vivo. After 14.8 +/- 0.2 h of 100% O2, 24 of 33 individuals had evidence of tracheobronchitis. Baseline gene expression of CuZn superoxide dismutase (SOD), MnSOD, and catalase in bronchial epithelium was very low (CuZnSOD 4.1 +/- 0.8 transcripts/cell, MnSOD 5.1 +/- 0.9, catalase 1.3 +/- 0.2), with control gamma-actin expression relatively abundant (50 +/- 6 transcripts/cell). Importantly, despite 100% O2 exposure sufficient to cause tracheobronchitis in most individuals, antioxidant mRNA transcripts/cell in bronchial epithelium did not increase (P > 0.5). Catalase activity in bronchial epithelium did not change after exposure to hyperoxia (P > 0.05). Total SOD activity increased mildly (P < 0.01) but not sufficiently to protect the epithelium. Together, the very low levels of expression of intracellular antioxidant enzymes and the inability to upregulate expression at the mRNA level with oxidant stress likely have a role in human airway epithelium susceptibility to hyperoxia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8226538     DOI: 10.1152/jappl.1993.75.3.1256

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  19 in total

Review 1.  Reactive oxygen species in inflammation and tissue injury.

Authors:  Manish Mittal; Mohammad Rizwan Siddiqui; Khiem Tran; Sekhar P Reddy; Asrar B Malik
Journal:  Antioxid Redox Signal       Date:  2013-10-22       Impact factor: 8.401

Review 2.  Redox control of asthma: molecular mechanisms and therapeutic opportunities.

Authors:  Suzy A A Comhair; Serpil C Erzurum
Journal:  Antioxid Redox Signal       Date:  2010-01       Impact factor: 8.401

3.  Deficiency of lung antioxidants in idiopathic pulmonary arterial hypertension.

Authors:  Fares A Masri; Suzy A A Comhair; Iva Dostanic-Larson; Francisco Takao Kaneko; Raed A Dweik; Alejandro C Arroliga; Serpil C Erzurum
Journal:  Clin Transl Sci       Date:  2008-09       Impact factor: 4.689

4.  Cell specific expression of peroxiredoxins in human lung and pulmonary sarcoidosis.

Authors:  V L Kinnula; S Lehtonen; R Kaarteenaho-Wiik; E Lakari; P Pääkkö; S W Kang; S G Rhee; Y Soini
Journal:  Thorax       Date:  2002-02       Impact factor: 9.139

5.  Correlation of systemic superoxide dismutase deficiency to airflow obstruction in asthma.

Authors:  Suzy A A Comhair; Kristin S Ricci; Mercedes Arroliga; Abigail R Lara; Raed A Dweik; Wei Song; Stanley L Hazen; Eugene R Bleecker; William W Busse; Kian Fan Chung; Benjamin Gaston; Annette Hastie; Mark Hew; Nizar Jarjour; Wendy Moore; Stephen Peters; W Gerald Teague; Sally E Wenzel; Serpil C Erzurum
Journal:  Am J Respir Crit Care Med       Date:  2005-05-05       Impact factor: 21.405

6.  Respiratory syncytial virus infection down-regulates antioxidant enzyme expression by triggering deacetylation-proteasomal degradation of Nrf2.

Authors:  Narayana Komaravelli; Bing Tian; Teodora Ivanciuc; Nicholas Mautemps; Allan R Brasier; Roberto P Garofalo; Antonella Casola
Journal:  Free Radic Biol Med       Date:  2015-06-11       Impact factor: 7.376

7.  Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo.

Authors:  F H Guo; H R De Raeve; T W Rice; D J Stuehr; F B Thunnissen; S C Erzurum
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

Review 8.  Genetic polymorphisms associated with acute lung injury.

Authors:  Anita J Reddy; Steven R Kleeberger
Journal:  Pharmacogenomics       Date:  2009-09       Impact factor: 2.533

9.  Neonatal therapy with PF543, a sphingosine kinase 1 inhibitor, ameliorates hyperoxia-induced airway remodeling in a murine model of bronchopulmonary dysplasia.

Authors:  Alison W Ha; Tara Sudhadevi; David L Ebenezer; Panfeng Fu; Evgeny V Berdyshev; Steven J Ackerman; Viswanathan Natarajan; Anantha Harijith
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-07-22       Impact factor: 5.464

Review 10.  Role of N-acetylcysteine in the management of COPD.

Authors:  Anna M Sadowska; J Verbraecken; K Darquennes; W A De Backer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.